Remove Development Remove Trial Funding Remove Trials
article thumbnail

Nektar lifted by Merck alliance for bempeg, new trial funding

pharmaphorum

Merck will pair Keytruda (pembrolizumab) with bempegaldesleukin (NKTR-214) – known as bempeg for short – in a phase 2/3 trial involving patients with squamous cell carcinoma of the head and neck (SCCHN) that if positive could support regulatory filings. That was signed for $1.8 That was signed for $1.8

article thumbnail

Government of Canada invests in clinical trial development in Canada through the Clinical Trials Fund

Pharma in Brief

On June 22, 2022, the Canadian Institutes of Health Research ( CIHR ) announced the launch of the Clinical Trials Fund ( CTF ), which will inject funding into Canada’s clinical trials environment. The Clinical Trials Fund. Clinical Trials Training Platforms ( CTTP ). Clinical Trials Projects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: ‘A blind eye’: NIH fails to ensure clinical trial results are reported and funds researchers who don’t file results

STAT News

National Institutes of Health failed to ensure that results of roughly half of clinical trials funded by the agency — both those conducted by its own scientists and outside researchers — were reported to a federal database during a recent two-year period, a new government review has found.

article thumbnail

Boston University taps Shimmer wearables for brain studies

Outsourcing Pharma

The trials, funded by the American Heart Association, will harness the companyâs Verisense wearable sensor platform to examine brain-heart health links.

article thumbnail

Decentralized Oncology Trials: Interview with Dr. Crystal S. Denlinger, CSO at NCCN

XTalks

The adoption of decentralized clinical trial (DCT) approaches has increased exponentially. Tools such as electronic consent, telehealth appointments and wearable devices have enabled investigators to contact trial participants virtually. Her work now focuses on leading NCCN’s Oncology Research Program ( ORP ), among other duties.

Trials 97
article thumbnail

Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail

pharmaphorum

The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that are being developed to both treat and prevent coronavirus infections. The phase 1 trialfunded by the US government – will take place in the UK and will test the safety of AZD7442 and its pharmacokinetic profile.